SCHEMBL23360684

SCHEMBL23360684

CN(C(=O)c1ccc(Br)c2cccnc12)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.48
TP53 P04637 2/20 0.48
MEN1 O00255 4/20 0.45
KDM4E B2RXH2 4/20 0.44
POLB P06746 1/20 0.44
L3MBTL1 Q9Y468 3/20 0.44
LMNA P02545 2/20 0.44
SLC40A1 Q9NP59 1/20 0.42
ALDH1A1 P00352 2/20 0.42
APAF1 O14727 1/20 0.42
TDP2 O95551 1/20 0.42
MAPT P10636 1/20 0.42
CASP3 P42574 1/20 0.42
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
SENP6 Q9GZR1 1/20 0.42
HTT P42858 2/20 0.41
KDM6B O15054 1/20 0.40
KDM6A O15550 1/20 0.40
TET3 O43151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23359872 0.85 KMT2A (0.47) KMT2ATP53MEN1KDM4EL3MBTL1
SCHEMBL29863233 0.85 KMT2A (0.47) KMT2ATP53MEN1KDM4EL3MBTL1
SCHEMBL23360445 0.81 HPGD (0.58) KMT2ATP53MEN1ALDH1A1MAPT
SCHEMBL1126280 0.78 KMT2A (0.62) KMT2ATP53MEN1KDM4EL3MBTL1
SCHEMBL6984750 0.78 LMNA (0.61) KMT2AKDM4EPOLBL3MBTL1LMNA
SCHEMBL2143852 0.75 ALDH1A1 (0.62) KMT2AKDM4EPOLBL3MBTL1LMNA
SCHEMBL16861478 0.74 KMT2A (0.51) KMT2ATP53MEN1KDM4EL3MBTL1
SCHEMBL20515237 0.74 KDM4E (0.59) KMT2ATP53MEN1KDM4EL3MBTL1
SCHEMBL23360051 0.73 KMT2A (0.53) KMT2ATP53MEN1KDM4EL3MBTL1
SCHEMBL15054071 0.73 KDM4E (0.62) KMT2ATP53MEN1KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4055014-B1 PYRROLIDINE AND PIPERIDINE COMPOUNDS YUHAN CORP (KR) 2025-04-30 EP disclosed
CN-114867719-B Pyrrolidine and piperidine compounds 柳韩洋行 2024-06-25 CN disclosed
US-11655235-B2 Pyrrolidine and piperidine compounds YUHAN CORPORATION (KR) 2023-05-23 US disclosed
EP-4055014-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS Yuhan Corporation (KR) 2022-09-14 EP disclosed
CN-114867719-A Pyrrolidine and piperidine compounds 柳韩洋行 2022-08-05 CN disclosed
US-20210147386-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS YUHAN CORPORATION (KR) 2021-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11655235-B2 Pyrrolidine and piperidine compounds FAP, APC, VHL KMT2A 2822/4885TP53 102/4885MEN1 2004/4885
US-20210147386-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS FAP, APC, VHL KMT2A 2822/4885TP53 102/4885MEN1 2004/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.